Učitavanje...
Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths
In a nationwide study of 3818 charts from patients with fatal COVID-19, we found that geographical differences in Dipeptidyl peptidase 4 (DPP4) inhibitors use did not correlate with diabetes prevalence among COVID-19 deaths, thus not supporting the hypothesis of a clinically relevant involvement of...
Spremljeno u:
| Izdano u: | Diabetes Res Clin Pract |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier B.V.
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7492144/ https://ncbi.nlm.nih.gov/pubmed/32946854 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.diabres.2020.108444 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|